Sunflower Pharmaceuticals Group Co Ltd Net Asset Quality Index
Sunflower Pharmaceuticals Group Co Ltd net asset quality index. Sunflower Pharmaceuticals Group Co Ltd (002737) has a Net Asset Quality Index of 76.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.36 Billion minus total liabilities of CN¥1.25 Billion yields net assets of CN¥4.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Sunflower Pharmaceuticals Group Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
Net asset quality index of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 76.7%, representing net assets of CN¥4.11 Billion against total assets of CN¥5.36 Billion CNY. Check 002737 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Sunflower Pharmaceuticals Group Co Ltd Net Asset Quality Index by Year (2011–2025)
Sunflower Pharmaceuticals Group Co Ltd net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Sunflower Pharmaceuticals Group Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.9% | CN¥3.99 Billion | CN¥5.33 Billion | CN¥1.34 Billion | ▼ -3.9 pp |
| 2024 | 78.8% | CN¥4.59 Billion | CN¥5.83 Billion | CN¥1.24 Billion | ▲ +6.1 pp |
| 2023 | 72.7% | CN¥5.00 Billion | CN¥6.88 Billion | CN¥1.88 Billion | ▲ +9.6 pp |
| 2022 | 63.1% | CN¥4.44 Billion | CN¥7.03 Billion | CN¥2.59 Billion | ▼ -6.7 pp |
| 2021 | 69.8% | CN¥3.94 Billion | CN¥5.64 Billion | CN¥1.70 Billion | ▲ +3.5 pp |
| 2020 | 66.3% | CN¥3.39 Billion | CN¥5.11 Billion | CN¥1.72 Billion | ▲ +1.7 pp |
| 2019 | 64.6% | CN¥3.43 Billion | CN¥5.31 Billion | CN¥1.88 Billion | ▼ -3.3 pp |
| 2018 | 67.9% | CN¥3.44 Billion | CN¥5.06 Billion | CN¥1.62 Billion | ▼ -2.8 pp |
| 2017 | 70.7% | CN¥3.16 Billion | CN¥4.47 Billion | CN¥1.31 Billion | ▲ +4.3 pp |
| 2016 | 66.4% | CN¥2.80 Billion | CN¥4.22 Billion | CN¥1.42 Billion | ▼ -2.9 pp |
| 2015 | 69.3% | CN¥2.61 Billion | CN¥3.76 Billion | CN¥1.15 Billion | ▲ +8.3 pp |
| 2014 | 61.1% | CN¥2.28 Billion | CN¥3.73 Billion | CN¥1.45 Billion | ▲ +19.7 pp |
| 2013 | 41.4% | CN¥869.02 Million | CN¥2.10 Billion | CN¥1.23 Billion | ▲ +1.4 pp |
| 2012 | 40.0% | CN¥758.39 Million | CN¥1.89 Billion | CN¥1.14 Billion | ▲ +5.1 pp |
| 2011 | 34.9% | CN¥543.47 Million | CN¥1.56 Billion | CN¥1.01 Billion | — |